Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Hemoperitoneum in Patients With Cirrhosis.

Autor: Abushamat F; University of California San Diego, San Diego, CA, USA., Dietrich CF; Clinic Hirslanden Bern Beau Site, Bern, Switzerland., Clevert DA; University of Munich-Grosshadern Campus, Munich, Germany., Piscaglia F; Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Fetzer DT; UT Southwestern Medical Center, Dallas, TX, USA., Meloni MF; University of Milan-Bicocca, Milan, Italy., Shiehmorteza M; University of California San Diego, San Diego, CA, USA., Kono Y; University of California San Diego, San Diego, CA, USA.
Jazyk: angličtina
Zdroj: Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine [J Ultrasound Med] 2023 Jan; Vol. 42 (1), pp. 247-253. Date of Electronic Publication: 2022 May 17.
DOI: 10.1002/jum.16002
Abstrakt: Hemoperitoneum in cirrhosis is a life-threatening condition that requires emergent evaluation. Contrast-enhanced ultrasound (CEUS) permits multiple dynamic characterizations of abdominal structures through all vascular phases, and contrast extravasation or the presence of microbubbles in the ascites could be a sensitive tool. We reviewed 13 patients with cirrhosis that underwent CEUS due to high suspicion for intra-abdominal bleeding. In 10 cases, CEUS demonstrated extravasation of contrast, including 2 instances where CEUS detected active bleeding despite negative computed tomography. These data support further study of CEUS in direct comparison to other imaging modalities in this clinical context.
(© 2022 American Institute of Ultrasound in Medicine.)
Databáze: MEDLINE
Externí odkaz: